{"id":15717,"name":"5AM Ventures","slug":"5am-ventures","website":"https://5amventures.com","hqGeo":"Boston, Massachusetts","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Life sciences venture firm focused on building and investing in biotechnology companies. Highly relevant for therapeutics and platform science, though usually not pre-seed first-check capital.","thesisNarrative":null,"logoUrl":null,"aumUsd":1500000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Nouscom","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Novira","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Panomics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pear","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pearl","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PhaseRx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Portal Instruments","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Precede Biosciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Precision NanoSystems","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Prolynx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pulmatrix","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Purigen Biosystems","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Radionetics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Rallybio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Portfolio company referenced by 5AM in a fund-raising announcement","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RareCyte","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Relypsa","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Potassium-binder biotech later acquired by Galenica","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Renasant Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Rennovia","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Reprotech","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Rezera","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Scientist.com","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"scPharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug-delivery pharmaceutical company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Semprus Biosciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Skye Bioscience, Inc.","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Surrozen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Synosia","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"VBI Vaccines","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Viveve","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vor Biopharma","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Wildcat","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Achaogen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharmaceutical company developing small-molecule therapeutics for multidrug-resistant bacterial infections","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Akouos","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Gene-therapy company for monogenic congenital deafness","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Alexza","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug-delivery biopharmaceutical company focused on pulmonary delivery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ambrx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Protein-drug engineering company combining recombinant protein synthesis and medicinal chemistry","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aprea","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Oncology biopharma developing mutant p53 reactivators","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Artiva","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Arvinas","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Small-molecule protein-degradation therapeutics company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Audentes","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Bellerophon","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Cardiopulmonary drug/device developer","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Bird Rock Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biologics company for rheumatoid arthritis and liver disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Bioz","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cabaletta Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Calibrium","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Camp4","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cellular Research","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ceterix Orthopedics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Chrono Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cidara","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CinCor Pharma","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Crinetics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Curie.Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Deverra","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Dianthus","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"DVS Sciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Life-science tools company for single-cell analysis","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Enliven","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ensoma","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Entrada Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Envoy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Epirus","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Escient","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Expansion","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Faraday","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Fellow Health","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Flexion","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"GlycoEra","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Halio, Inc.","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Homology","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ideaya","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Igenica","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ikaria","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Critical-care biopharma company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ilypsa","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug-development company later acquired by Amgen","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Impel Neuropharma","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Incline","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Inipharm","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kalobios","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Karius","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kinaset","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Latigo Biotherapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lifordi Immunotherapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Magnetic Insight","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Marcadia","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mendra, Inc.","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Miikana","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Millendo","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"nChroma Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neurogastrx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Nido Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Crinetics Pharmaceuticals","companyUrl":null,"stage":"portfolio company","sector":"biopharma","investmentYear":null,"description":"Biopharma company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Enliven Therapeutics","companyUrl":null,"stage":"public/IPO","sector":"biopharma","investmentYear":null,"description":"Public biotech company included among 5AM’s recent public-market exits","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Envoy Therapeutics","companyUrl":null,"stage":"exit","sector":"biopharma","investmentYear":null,"description":"Therapeutics company acquired by Takeda","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Flexion Therapeutics","companyUrl":null,"stage":"exit","sector":"biopharma","investmentYear":null,"description":"Biopharmaceutical company for musculoskeletal pain","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Homology Medicines","companyUrl":null,"stage":"portfolio company","sector":"biopharma / gene therapy","investmentYear":null,"description":"Gene-therapy company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Artiva Biotherapeutics","companyUrl":null,"stage":"portfolio company","sector":"biopharma / cell therapy","investmentYear":null,"description":"Allogeneic NK-cell therapy company for cancer","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Audentes Therapeutics","companyUrl":null,"stage":"portfolio company","sector":"biopharma / gene therapy","investmentYear":null,"description":"Gene-therapy company for serious rare diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cidara Therapeutics","companyUrl":null,"stage":"Series A and Series B","sector":"biopharma / infectious disease","investmentYear":null,"description":"Antibody-drug conjugate and anti-infective company","amountUsd":null,"relevanceNote":null,"fundName":"Series A and Series B"},{"companyName":"Incline Therapeutics","companyUrl":null,"stage":"exit","sector":"biopharma / drug delivery","investmentYear":null,"description":"Drug-delivery company acquired by The Medicines Company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Marcadia Biotech","companyUrl":null,"stage":"exit","sector":"biopharma","investmentYear":null,"description":"Biotech company acquired by Roche","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Novira Therapeutics","companyUrl":null,"stage":"exit","sector":"biopharma","investmentYear":null,"description":"Biotech company acquired by Johnson & Johnson","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pearl Therapeutics","companyUrl":null,"stage":"exit","sector":"biopharma","investmentYear":null,"description":"Respiratory therapeutics company acquired by AstraZeneca","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":10,"partners":[{"id":51236,"name":"Andy Schwab","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51239,"name":"Brian Daniels","title":"Venture Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51241,"name":"Michael Calore","title":"Head of Investor Relations","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/michael-calore-0b74a39","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51238,"name":"Anna Yaeger","title":"Head of Public Equities","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/anna-cosslett-yaeger-533b7917a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51243,"name":"Katie Spielberg","title":"Principal","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/katie-bodner-spielberg-72b50363","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51247,"name":"Kush Parmar","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/kush-parmar-m-d-ph-d-5165582","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51251,"name":"Specific partner not identified in source","title":"Partner","seniority":null,"focusTags":["biotech","company creation"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51248,"name":"John Diekman","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/john-diekman-38096036","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51249,"name":"John Kelly","title":"Chief Financial Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/john-kelly-21aa1372","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51250,"name":"Jami Wiegand","title":"Manager, Information Technology","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/jamiwiegand","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":594,"name":"Fund IV","vintageYear":2020,"sizeUsd":250000000,"status":"investing","focusAreas":[]},{"id":593,"name":"Fund III","vintageYear":2017,"sizeUsd":200000000,"status":"closed","focusAreas":[]},{"id":592,"name":"Fund II","vintageYear":2013,"sizeUsd":150000000,"status":"closed","focusAreas":[]},{"id":591,"name":"Fund I","vintageYear":2009,"sizeUsd":100000000,"status":"closed","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[],"contentUpdatedAt":null,"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-22T15:11:21.105Z"}